Ohio State Navbar

Sign In


Methods and Compositions for Detecting and Treating End-Stage Cardiomyopathy by Measuring Claudin-5. Mays T, Binkley P ,Janssen P ,*Rafael-Fortney J. 2008  
Treatment of Metabolic-Related Disorders using Hypothalamic Gene Transfer of BDNF and Composition Therefore. *During Matthew,Cao L. 2008
Novel Methylenedioxy Phenolic Compounds and Their Use to Treat Disease. Rajagopalan S,*Parthasarathy S, Rajagopalan D. 2008
Compositions and Methods for Inhibition of Smooth Muscle Cell Proliferation and Neointimal Hyperplasia. *Kuppusamy P, Hideg K. 2008
Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof. Georgantas R, Calin G, Civin C, *Croce C. 2008
MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders. Ambs S, *Croce C. 2008
System for Modulating Expression of Hypothalamic Brain-Derived Neurotrophic Factor (BDNF). *During M,  Cao L. 2008
Digital Distance Measurer for Nerve Conduction Studies. Tu J, *Kerner T, Bartsch J. 2008
High-resolution digital image processing in the analysis of pathological materials. *Barsky S. 2008
Diagnostic, Prognostic And Therapeutic Uses Of Micro(Mi)RNA 19b In Idiopathic Pulmonary Fibrosis. Hunter M, Dakhlallah D, *Marsh C. 2008
Use of miR-17~92 MicroRNA Cluster as a Companion Diagnostic to 5'-Aza-Deoxycytidine Treatment for Fibrotic Diseases. Hunter M, Dakhlallah D, *Marsh C. 2008
Immunogenic Epitopes, Peptidomimetics, and Anti-Peptide Antibodies, and Methods of Their Use. Kaumaya P. 2008
Methods and Compositions for Delivering Therapeutic Agents in the Treatment of B-Cell Disorders. Byrd J, Muthusamy N, Lee R, Lee L. 2009
Anti-miR-1 Therapy for Wound Healing. Sen C, Goldberg-Shilo S, Roy S. 2009
Therapeutic Agent and Method. Pancholi, V. 2009
Method for Testing an Agent for Strokes in Humans with a Non-Human Stroke Model. Sen C, Rink C, Roy S, Christoforidis G. 2009
Polymorphism in CYP3A4 Gene Affecting Drug Metabolizing and Uses Thereof. Yingying G, Wang D, Wrighton S, Sadee W. 2009
System for Detection of Occult Murine Cytomegalovirus (MCMV). Cook C, 2009
Rapid Genotyping of SNPs. Wu H, Yang S, X L-H. 2009
Surgical Device, Method of Performing Surgery Using Same and Surgical Device Kit. Porshinsky B. 2009
Methods and Compositions for Targeting of BMI-1 Oncogene/Stem cell Renewal Factor Using Microrna-128 to Inhibit Glioma Proliferation and Self-Renewal. Lawler S, Chiocca EA, Godlewski J. 2009
Platelet Production Methods. Lasky L, Sullenbarger B, Kotov N. 2009
Tcl-1 Functions as a Transcriptional Regulator. Croce C, Pekarsky Y. 2009
Method for Sharing Data Between Data Sets with Differentially Encoded Data. Simonetti O, Ding Y, Lin H-Y, Chung Y-C. 2009
MicroRNA Expression Profiling and Targeting in Chronic Obstructive Pulmonary
Disease (COPD) Lung Tissue and Methods of Use Thereof. Nana-Sinkam P, Diaz P, Ezzie M. 2009
Hematopoietic Protein Tyrosine Phosphatase Mediates b2-Adrenergic Receptor-induced Regulation of p38 MAPK in B Lymphocytes. Sander V, McAlees J. 2009
ETS-2 Biomarkers for Fibrotic Diseases and Uses Thereof. Marsh C, Baran C. 2009
Liposomes with Cholesteryl-9-Carboxynonanoate as Macrophage-targeted MRI Probes in Atherosclerosis. Rajagopalan S, Parthasarathy S, Maiseyeu A. 2009
Wound Goggles. Sen C, Xu R. 2009
Compositions, Methods, and Systems for Monitoring Oxygen. Kuppusamy P. 2009
B Cell Depletion for Central Nervous System Injuries and Methods and Uses Thereof. Popovich P, Ankeny D, Cambier J. 2009
Therapeutic Method and Composition. Pancholi V. 2010
Multi-Functional Biodegradable Particles for Selectable Targeting, Imaging, and Therapeutic Delivery and Use Thereof for Treating Ocular Disorders. Xu R. Roberts C, Zhang L. 2010
Dark-Blood Whole Body Vessel Wall Imaging Method. Mihai G, Chung Y-C, Simonetti O, Rajagopalan S. 2010
Materials and Methods Useful for Affecting Tumor Cell Growth, Migration and Invasion. De la Chapelle A, Liyanarachchi S, He H, Shen R, Li W. 2010
Regulated Cell-Based Delivery of Viruses. Nakashima H, Chiocca EA. 2010
Composition and Method for Converting a Non-Pathogenic Prion Protein into a Pathogenic Conformation and Uses Thereof. Ma J, Wang X, Wang F. 2010
MicroRNA Expression in Progression and Prognosis of Gastric Cancer. Croce C. 2010
Cell Capture Materials and Methods. Moldovan N. 2010
Materials and Methods Related to modulation of Mismatch Repair and genomic Stability by MIR-155. Croce C, Valeri N. 2010
Application of PKCbeta Inhibitors in Treatment of Obesity and/or Diabetes. Mehta K. 2010
Combined Treatment of Cancer with Benzo[e]pyridoindoles and DNA-damaging Agents. Nakano I, Molla A, Nguyen C-H. 2010
Stabilization of HIF-2 Induces SVEGFR-1 Production and Enhances the Anti-Tumor Effects of GM-CSF in a Murine Melanoma Model. Marsh C, Roda J, Eubank T. 2011
Use of Polymorphisms in the Prediction of Cardiovascular Risks. Sadee W, Papp A. 2011
Nitrotyrosinylated Fatty Acid Binding Protein and Myoglobin for the Detection of Myocardial Injury. Gumina R, Wheeler D. 2011
Promoter Sequences and Uses Thereof. Trgovcich J. Das Mukhopadhyay C, Cook C, Jonjic S, Juranic Lisnic V. 2011
Compounds for Detection of Aggregated Tau Proteins. Kuret J, Cisek K, Jensen J. 2011
Gallocatechin 5-O-gallate and Related Compositions and Methods. Abdel-Rahman M, Davidorf F, Salem M. 2011
Silvestrol and Uses Thereof. Baiocchi R, Patton J, Lucas D, Grever M, Kinghorn AD.2011